QualityStocksNewsBreaks Archives - Page 974 of 1453

WednesdayApr 22, 2020 10:21 am

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) Management Featured in Cleantech and Climate Change Podcast – Earth Day Interview

SinglePoint (OTCQB: SING) today announced that its President and Director William Ralston and Chief Financial Officer Corey A. Lambrecht were featured in a Cleantech and Climate Change Podcast - Earth Day Interview. According to the update, Investorideas.com, a global news source and leading investor resource covering cleantech and renewable energy stocks (Renewableenergystocks.com) issued the Earth Day special edition of the podcast. In the interview, SinglePoint management discuss the future of solar and the scalability and adaptability of SING’s Direct Solar subsidiary. “With what is going on in the global market and with the pandemic, it's a world imagining where we…

WednesdayApr 22, 2020 10:13 am

QualityStocksNewsBreaks – Cannabis Global, Inc. (MCTC) and Sugarmade, Inc.’s (SGMD) BudCars Enter License Agreement for Production of Super-Premium Edibles for the California Marketplace

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced the licensing of several patent-pending technologies to Sugarmade’s (OTCQB: SGMD) Sacramento-based BudCars Cannabis Delivery Service for use in cannabis edibles for the regulated California marketplace. Under the agreement, Cannabis Global will license its unique cannabinoid infusion technologies to BudCars for the production of super-premium, highly bioavailable cannabis edibles. “We have developed and have pending patents on several technologies that not only make the production of cannabis edibles less expensive but also improve product quality. While we are rolling out our own…

WednesdayApr 22, 2020 9:25 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Research Partner Secures Steady Psilocybin Supply for Clinical Studies

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human optimization sciences company that is advancing its clinical pipeline through its ongoing TBI/PTSD-focused preclinical studies at the University of Miami’s Miller School of Medicine, today announced that its research partner and lead investigator, Dr. Michael Hoffer, has obtained a sustainable supply of psilocybin under a DEA schedule I license, which will be used for ongoing psilocybin-based therapeutics studies. Under a collaborative research agreement with the University of Miami's Miller School of Medicine, Champignon’s wholly owned subsidiary, Tassili Life Sciences Corp., is conducting preclinical studies and eventual human clinical trials, with…

TuesdayApr 21, 2020 1:33 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Wins the Inaugural LD Micro March Madness Tournament

SRAX (NASDAQ: SRAX), a digital marketing and consumer data management technology company, won the inaugural LD Micro March Madness tournament. SRAX was the lowest seed remaining in the competition after it made the “Sweet 16,” and managed to secure the win. The company recently launched its Stock for Ads Program, offering media solutions for stock payments to help businesses connect with their clients and protect cash during this critical time. LD Micro noted that the company’s ability to remain active, transparent, and monetarily responsible during this time will pay big dividends in the future. SRAX has paid to attend LD…

TuesdayApr 21, 2020 11:20 am

QualityStocksNewsBreaks – InsuraGuest Technologies Inc. (TSX.V: ISGI) Licensed to Sell All Lines of Insurance in 47 US States, Including California and Florida

InsuraGuest Technologies (TSX.V: ISGI) today announced that its wholly owned U.S. subsidiary, InsuraGuest Insurance Agency, LLC (the “Agency”), is now licensed to sell all lines of insurance in 47 out of the 50 U.S. states and Washington, D.C. According to the update, the Agency is registered and licensed to sell accident and health, casualty, life and property insurance in the District of Columbia and all states with exception to Massachusetts, New York and Washington, where it has submitted application and expects to be approved to sell insurance within the next 30 days in these three remaining states. “As the world…

TuesdayApr 21, 2020 10:52 am

QualityStocksNewsBreaks – OriginClear, Inc. (OCLN) Relocates Corporate Headquarters to Combine with its Texas-Based Manufacturing Site

OriginClear (OTCQB: OCLN), a leading provider of water treatment solutions, today announced that it has relocated its corporate headquarters from Los Angeles to combine with its manufacturing site in McKinney, near Dallas, Texas. “We have enjoyed our stay at the La Kretz Campus of the Los Angeles Cleantech Incubator complex, including its extraordinary prototyping resources and its dedicated team,” OriginClear CEO Riggs Eckelberry said in the news release. “But increasingly, our California team has been virtual, and both development and manufacturing have been centered on our Texas location. This move reflects that fact.” To view the full press release, visit…

TuesdayApr 21, 2020 10:43 am

QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Appoints Accomplished Executive Shannon Inman to Drive Launch of Key Clinical Trials

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced the appointment of Shannon Inman as Vice President of Global Clinical Operations. According to the update, Inman will lead in defining clinical developmental strategies, clinical protocol design, study conduct, and managing risk assessment in this new position. These clinical trials include those with Genprex’s lead drug candidate, Oncoprex(TM), for non-small cell lung cancer (“NSCLC”), which recently received Fast Track Designation for its combination with osimertinib, AstraZeneca’s first-line targeted EGFR TKI drug Tagrisso(R). “Genprex continues to strengthen its leadership team with…

TuesdayApr 21, 2020 10:20 am

QualityStocksNewsBreaks – Cannabis Global, Inc. (MCTC) Announces New Line of Cannabinoid Beverage Infusion Technologies and Industry’s First THC-V Tea and Coffee Products

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced a new line of cannabinoid beverage infusion technologies and the industry's first Tetrahydrocannabivarin (“THC-V”) tea and coffee products. According to the update, the Company plans to begin marketing both the infusion technologies and the tea and coffee products beginning May 1, 2020. "We have completed our product development into combining THC-V and other rare cannabinoids into infusion substrates, which can then be easily added to virtually any beverage or into many foods,” Cannabis Global CEO Arman Tabatabaei said in the news…

TuesdayApr 21, 2020 10:15 am

QualityStocksNewsBreaks – Youngevity International, Inc. (NASDAQ: YGYI) Subsidiaries Enter Joint Venture for Large Scale Processing Facility, 2,200 Acres to Grow Hemp in Nicaragua

Youngevity International (NASDAQ: YGYI), a multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise, commercial hemp enterprise and multi-channel lifestyle company, today announced that its wholly-owned subsidiaries, CLR Roasters LLC and Khrysos Industries, Inc. (the "US Partners") have entered into an agreement with H&H Coffee Group Export Corp and The Nica Hemp Cooperative, Inc (the "Nicaragua Partners") to acquire the 2,200 acre Chaguitillo Farms in Sebaco-Matagalpa, Nicaragua. The joint venture will utilize the property to erect a large-scale processing facility and to grow hemp on the land. Planned improvements to the property are anticipated to…

TuesdayApr 21, 2020 9:46 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Files New Patent Application for DehydraTECH Technology in Delivery of Antiviral Drugs

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced that it has filed an important new patent application in the United States describing the use of its DehydraTECH(TM) technology for the delivery of antiviral drugs. According to the update, the technology would potentially be used to improve treatment options for viral infectious diseases including COVID-19, MERS, SARS, influenza, herpes, hepatitis and AIDS. "Lexaria's proprietary drug delivery platform has already proven its effectiveness in the oral delivery of other lipophilic drugs such as nicotine, cannabinoids, and more, with multi-fold increases in both the rate…

Site Search

Company Search

Category: QualityStocksNewsBreaks